Not going to come. After over 25 years of promises ADO still does not qualify to be a "penny stock"
Anteo Diagnostics, before becoming AnteoTech Limited, had a history of name changes. It began as Polymerat Pty Ltd in 1999, later becoming Biolayer Pty Ltd in 2004, and then SSH Medical after a backdoor listing in 2005. The name change to Anteo Diagnostics occurred in late 2008. In November 2019, it was further renamed to AnteoTech Limited.
Nobody in this company, ever, has known how to close a deal and make a sale. If the technology is as good as ADO claims, prospective customers would be chasing us to close an exclusive deal with them. There's never been any monthly reporting about who the prospects are and at what stage we are at, as far as a deal in concerned. Trade Fairs are a waste of money. Nothing beats face to face negotiating and selling. It is simply unbelieveable how we could not have made a deal by now. This will be like Covid all over again. EVs will be on the way out and we will never have made a deal.
Well that's my frustration over for the day. We can only hope I'm wrong, but I suspect there is no firm deal on the horizojn and once again the money is running low.
ADO Price at posting:
0.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)